| Mistletoe |
|
|
Iscador and Helixor Therapy The use of mistletoe (Viscum album) has been in clinical use since the 1920's. Mistletoe is a parasitic plant that can be found growing on a number of different tree species. Depending on the specific tress species it is found, mistletoe extracts have varying levels of effectiveness in regards toThe original information of its potential use was put forward by Dr. Rudolf Steiner with subsequent product development by Dr. I Wegman in Switzerland Its usefulness as a therapy comes from two primary functions: inhibition of tumor growth (cytostatic) and immune stimulation (immunomodulatory). Bone marrow stimulation is a secondary effect that can benefit certain cases. More specifically, effects of the therapy include: improved immune (NK cell) response to cancer cells, differentiation of cancer cells, pain relief, reduction in cancer spread (metastases) and weight gain. Mistletoe therapy has also shown to be compatible with all other forms of therapy, conventional or complementary, making it an effective, safe and simple adjunct to cancer care. Generally mistletoe therapy is provided in two phases: 1) Induction Phase - initiation of therapy which allows the determination of dose and type best suited for the patient. 2) Maintenance Phase - active support phase of the therapy ADMINISTRATION
For more information call 403-288-4880 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|